Gout
Gout management, including treat-to-target urate lowering.
Papers per year
Each bar is 12 months; the last one ends 17 Oct 2026. New trials in the same years: 31, 31, 36, 41, 45.
New guidelines and consensus this year
- Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions for disease elements in calcium pyrophosphate crystal deposition (CPPD)Ann Rheum Dis2026 Jun 9
- Tophus severity grading and surgical treatment: Chinese Medical Doctor Association Multidisciplinary Expert Consensus Statement and Recommendations, 2025Int J Surg2026 Jan 1
All papers from the last 12 months
1,210 papers (18 Oct 2025 – 17 Oct 2026), newest first. Loading the full list…
- A decade iterative development of MOF-based uric acid luminescent sensors (2016-2026): From design strategy, mechanistic insights to portable detectionTalanta2027 Jan 1PMID 42435544Review
- CA72-4 derived from synovial cells inhibits monosodium urate-induced macrophage M1 polarization by activating the TIGIT/SHP-1 axis through binding to Siglec-15Autoimmunity2026 Dec 31PMID 41920724
- Meta-analysis of handgrip strength in subjects with high-normal or mildly increased uric acid compared to low-normal levels reported as quartilesGynecol Endocrinol2026 Dec 31PMID 41486688Meta-analysisSystematic review
- Multisystem effects of sodium-glucose cotransporter-2 inhibitors beyond glycaemic control: an umbrella review of systematic reviews and meta-analysesJ Diabetes Metab Disord2026 DecPMID 42856812Review
- Gut microbiota-mediated uric acid metabolism: Novel insights for developing urate-lowering and anti-gout medicationsPharm Sci Adv2026 DecPMID 42751478Review
- Integrated transcriptomics and metabolomics reveal suppression of the PPAR α/γ pathway linking purine metabolism disorder to high-protein diet-induced hyperuricemia in goslingsAnim Nutr2026 DecPMID 42741484
- Single-atom nanozyme-based wireless microfluidic sensing platform for noninvasive hyperuricemia diagnosisBiosens Bioelectron2026 Dec 1PMID 42571737
- Male reproductive surgeries and long-term kidney outcomes: a Mendelian randomization and meta-analysis of UK Biobank and FinnGenRen Fail2026 DecPMID 42549566Meta-analysis
- Regarding 'incidence and prevalence of gout in Eastern China from 2011 to 2021: a retrospective population-based study'Ann Med2026 DecPMID 41574931
- Repurposing the anti-gout drug benzbromarone for the treatment of gliomaCell Cycle2026 DecPMID 41201217
More rheumatology trends
All specialties →Giant cell arteritis and PMR
Giant cell arteritis, polymyalgia rheumatica and steroid-sparing treatment.
Key point: In PMR, interleukin-6 receptor blockers should be considered with glucocorticoids for relapsing disease and can be considered for new-onset high-risk patients.
Psoriatic arthritis
Psoriatic arthritis and its targeted treatments.
JAK inhibitors in rheumatoid arthritis
JAK inhibitors in RA, including their safety.
Axial spondyloarthritis
Diagnosis and treatment of axial spondyloarthritis.
Myositis
Inflammatory myopathies, including dermatomyositis.
VEXAS syndrome
An adult-onset autoinflammatory syndrome caused by UBA1 mutations.
Too many papers to read?
PubDaily picks the ones that matter in your specialty and summarises them, about 10 minutes a week.
How these numbers are counted
PubMed query, searched in titles and abstracts by publication date:
gout[tiab]Trials: ClinicalTrials.gov studies first submitted in each 12-month window that match the same terms. A query can miss synonyms or catch unrelated papers, so treat counts as approximate.